Skip to main content

Table 2 Percentage of neoadjuvant therapy performed in each time period in clinical stage UICC III patients

From: Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Neoadjuvant-Therapy in clinical stage

1993-2001 (n=142)

2002. 2010 (n=204)

p-value

cUICC II/III

No.

%

No.

%

No

102

71.8

32

15.7

<0.001

Chemo

1

0.7

0

0

n.s.

Radio

29

20.4

102

50.0

<0.001

Radiochemo

10

7.0

70

34.3

<0.001